Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
15.32
-0.20 (-1.29%)
At close: Sep 2, 2025, 4:00 PM
15.40
+0.08 (0.52%)
After-hours: Sep 2, 2025, 7:17 PM EDT
Arcutis Biotherapeutics Employees
Arcutis Biotherapeutics had 342 employees as of December 31, 2024. The number of employees increased by 46 or 15.54% compared to the previous year.
Employees
342
Change (1Y)
46
Growth (1Y)
15.54%
Revenue / Employee
$770,365
Profits / Employee
-$272,722
Market Cap
1.84B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 342 | 46 | 15.54% |
| Dec 31, 2023 | 296 | 28 | 10.45% |
| Dec 31, 2022 | 268 | 121 | 82.31% |
| Dec 31, 2021 | 147 | 93 | 172.22% |
| Dec 31, 2020 | 54 | 25 | 86.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ARQT News
- 10 days ago - Arcutis: ZORYVE's Multi-Indication Momentum And Margin Expansion Justify A Bullish Re-Rate - Seeking Alpha
- 14 days ago - Arcutis to Present at Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - Arcutis Biotherapeutics, Inc. (ARQT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Arcutis Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Arcutis: Leveraging Zoryve's Success While Positioning For Pipeline Expansion - Seeking Alpha
- 5 weeks ago - Arcutis to Report Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025 - GlobeNewsWire
- 2 months ago - Arcutis Biotherapeutics: A Closer Look At The Atopic Dermatitis Direction - Seeking Alpha